Literature DB >> 14980376

Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities.

Harvey S Singer1, Karen Minzer.   

Abstract

Despite a preponderance of evidence suggesting an organic rather than psychogenic origin for Tourette syndrome, the precise neurobiological abnormality remains speculative. Neuroanatomically, there is expanding confirmation that cortico-striato-thalamo-cortical pathways represent the site of origin for tics and accompanying neuropsychiatric problems. Pathophysiological hypothesis are generally defined based on involvement of (1) a specific anatomical site (striato-thalamic circuits, striatal compartments), (2) physiologic abnormality (excess thalamic excitation, impaired intracortical inhibition), or (3) involvement of a specific neurotransmitter or synaptic component. This review provides information essential for understanding current and future proposals pertaining to the neurobiology of this intriguing disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14980376     DOI: 10.1016/s0387-7604(03)90012-x

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  46 in total

1.  Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region.

Authors:  P Paschou; Y Feng; A J Pakstis; W C Speed; M M DeMille; J R Kidd; B Jaghori; R Kurlan; D L Pauls; P Sandor; C L Barr; K K Kidd
Journal:  Am J Hum Genet       Date:  2004-08-09       Impact factor: 11.025

Review 2.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

3.  Distinct FGFs promote differentiation of excitatory and inhibitory synapses.

Authors:  Akiko Terauchi; Erin M Johnson-Venkatesh; Anna B Toth; Danish Javed; Michael A Sutton; Hisashi Umemori
Journal:  Nature       Date:  2010-05-26       Impact factor: 49.962

4.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Authors:  Lior Brimberg; Itai Benhar; Adita Mascaro-Blanco; Kathy Alvarez; Dafna Lotan; Christine Winter; Julia Klein; Allon E Moses; Finn E Somnier; James F Leckman; Susan E Swedo; Madeleine W Cunningham; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

5.  Thinning of sensorimotor cortices in children with Tourette syndrome.

Authors:  Elizabeth R Sowell; Eric Kan; June Yoshii; Paul M Thompson; Ravi Bansal; Dongrong Xu; Arthur W Toga; Bradley S Peterson
Journal:  Nat Neurosci       Date:  2008-05-18       Impact factor: 24.884

6.  Altered motor network recruitment during finger tapping in boys with Tourette syndrome.

Authors:  Veit Roessner; Matthias Wittfoth; Carsten Schmidt-Samoa; Aribert Rothenberger; Peter Dechent; Jürgen Baudewig
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

Review 7.  Specific sets of intrinsic and extrinsic factors drive excitatory and inhibitory circuit formation.

Authors:  Akiko Terauchi; Hisashi Umemori
Journal:  Neuroscientist       Date:  2011-06-07       Impact factor: 7.519

8.  Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

Authors:  J P Q Zhu; W Xu; J A Angulo
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

9.  Levetiracetam as an alternative therapy for Tourette syndrome.

Authors:  M A Martínez-Granero; A García-Pérez; F Montañes
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

10.  Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study.

Authors:  Samuel R Chamberlain; Lara A Menzies; Naomi A Fineberg; Natalia Del Campo; John Suckling; Kevin Craig; Ulrich Müller; Trevor W Robbins; Edward T Bullmore; Barbara J Sahakian
Journal:  Br J Psychiatry       Date:  2008-09       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.